I have never met them, nor have I ever thanked them for their part in my survival. And yet so much of that day and my treatment in the following months depended on their expertise.
Ovarian cancer is the second most common type of gynecological cancer, but it is also the most lethal because it is usually detected at later stages when it is more difficult to treat, which is why early detection is so important.
Not necessarily. Elevated CA-125 (a protein in the blood that’s associated with ovarian cancer) is most often caused by common, ordinary or benign conditions such as uterine fibroids, ovarian cysts, endometriosis — or even just having your period.
We asked some of Roswell Park’s doctors who specialize in cancers that affect women to share some tips for preventing or treating cancer. Here’s what they offered.
I tried to ignore the pain and the feeling of being “off.” But one day, after struggling through a few minutes of yet another bad run, I stopped in mid-stride, pulled out my phone, and called my doctor.
A team of Roswell Park researchers that includes an ambitious high school student has given women everywhere another good reason to eat their veggies.
By studying similarities in high-risk individuals and tracing connections between their blood relatives, researchers are helping solve the mysteries of a disease that is usually diagnosed in the late stages, when it is harder to treat.
One reason this finding is so exciting is that we can now focus on the X chromosome to find the gene mutations that put women at higher risk of ovarian cancer and men at higher risk of testicular cancer.
The average woman’s risk of developing ovarian cancer at some point in her life is relatively small (1.4%), but some women are at higher risk than others.
We have heard lots of information lately about talcum powder use and the risk of ovarian cancer. Let’s step back and look at the facts.
“Initially, ovarian cancer, melanoma, and some sarcomas are the three main targets,” says Dr. Koya, “but the clinical trial is open for patients with other cancers who meet the eligibility requirements."